rabeprazole 10 milligram tablets gastro-resistant
mcdermott laboratories ltd t/a gerard laboratories - rabeprazole sodium - tablets gastro-resistant - 10 milligram - proton pump inhibitors
rabeprazole 20 milligram tablets gastro-resistant
mcdermott laboratories ltd t/a gerard laboratories - rabeprazole sodium - tablets gastro-resistant - 20 milligram - proton pump inhibitors
rabeprazole-asteria tablets film-coated
hankook korus pharm co. - rabeprazole (rabeprazole sodium) - tablets film-coated - 20mg
rabeprazole-asteria tablets film-coated
hankook korus pharm co. - rabeprazole (rabeprazole sodium) - tablets film-coated - 20mg
zulbex tablets gastro-resistant
krka d.d. - rabeprazole (rabeprazole sodium) - tablets gastro-resistant - 10mg
zulbex tablets gastro-resistant
krka d.d. - rabeprazole (rabeprazole sodium) - tablets gastro-resistant - 20mg
rabeprazole krka 10mg gastro-resistant tablets
krka, d.d., novo mesto - rabeprazole sodium - gastro-resistant tablet - 10 milligram(s) - proton pump inhibitors; rabeprazole
rabeprazole krka 20mg gastro-resistant tablets
krka, d.d., novo mesto - rabeprazole sodium - gastro-resistant tablet - 20 milligram(s) - proton pump inhibitors; rabeprazole
razole 10 mg gastro-resistant tablets
rowa pharmaceuticals limited - rabeprazole sodium - gastro-resistant tablet - 10 milligram(s) - proton pump inhibitors; rabeprazole - alimentary tract and metabolism, drugs for peptic ulcer and gastro-oesophageal reflux disease (gord), proton pump inhibitors - it is indicated in: active duodenal ulcer; active benign gastric ulcer; symptomatic erosive or ulcerative gastro-oesophageal reflux disease (gord); gastro-oesophageal reflux disease, long-term management (gord maintenance); symptomatic treatment of moderate to very severe gastro-oesophageal reflux disease (symptomatic gord) zollinger-ellison syndrome; in combination with appropriate antibacterial therapeutic regimens for the eradication of helicobacter pylori in patients with peptic ulcer disease
razole 20 mg gastro-resistant tablets
rowa pharmaceuticals limited - rabeprazole sodium - gastro-resistant tablet - 20 milligram(s) - proton pump inhibitors; rabeprazole - alimentary tract and metabolism, drugs for peptic ulcer and gastro-oesophageal reflux disease (gord), proton pump inhibitors - it is indicated in: active duodenal ulcer; active benign gastric ulcer; symptomatic erosive or ulcerative gastro-oesophageal reflux disease (gord); gastro-oesophageal reflux disease, long-term management (gord maintenance); symptomatic treatment of moderate to very severe gastro-oesophageal reflux disease (symptomatic gord) zollinger-ellison syndrome; in combination with appropriate antibacterial therapeutic regimens for the eradication of helicobacter pylori in patients with peptic ulcer disease.